Cargando...

A Kinetic Model Explains Why Shorter and Less Affine Enzyme-recruiting Oligonucleotides Can Be More Potent

Antisense oligonucleotides complementary to RNA targets promise generality and ease of drug design. The first systemically administered antisense drug was recently approved for treatment and others are in clinical development. Chemical modifications that increase the hybridization affinity of oligon...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Pedersen, Lykke, Hagedorn, Peter H, Lindholm, Marie Wickström, Lindow, Morten
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2014
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3951909/
https://ncbi.nlm.nih.gov/pubmed/24549300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mtna.2013.72
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!